S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
Log in
NYSE:DHR

Danaher Stock Forecast, Price & News

$218.35
+3.94 (+1.84 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$212.55
Now: $218.35
$219.32
50-Day Range
$214.41
MA: $233.80
$245.90
52-Week Range
$119.60
Now: $218.35
$248.86
Volume2.43 million shs
Average Volume2.62 million shs
Market Capitalization$155.51 billion
P/E Ratio44.20
Dividend Yield0.33%
Beta0.72
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Danaher logo

Headlines

Why Is Danaher (DHR) Down 3.9% Since Last Earnings Report?
February 27, 2021 |  finance.yahoo.com
Oversold Conditions For Danaher (DHR) - Nasdaq
February 25, 2021 |  nasdaq.com
Danaher Announces Quarterly Dividends - Yahoo Finance
February 23, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
CUSIP23585110
Phone202-828-0850
Employees60,000
Year Founded1984

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$17.91 billion
Cash Flow$5.66 per share
Book Value$39.93 per share

Profitability

Net Income$3.01 billion

Miscellaneous

Market Cap$155.51 billion
Next Earnings Date5/5/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.95 out of 5 stars

Multi-Sector Conglomerates Sector

8th out of 44 stocks

Process Control Instruments Industry

3rd out of 25 stocks

Analyst Opinion: 1.4Community Rank: 3.1Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
$218.35
+3.94 (+1.84 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DHR News and Ratings via Email

Sign-up to receive the latest news and ratings for DHR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Danaher (NYSE:DHR) Frequently Asked Questions

Is Danaher a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last twelve months. There are currently 2 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Danaher stock.
View analyst ratings for Danaher
or view top-rated stocks.

What stocks does MarketBeat like better than Danaher?

Wall Street analysts have given Danaher a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Danaher wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Danaher's next earnings date?

Danaher is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Danaher
.

How were Danaher's earnings last quarter?

Danaher Co. (NYSE:DHR) released its earnings results on Thursday, January, 28th. The conglomerate reported $2.08 EPS for the quarter, topping the consensus estimate of $1.84 by $0.24. The conglomerate had revenue of $6.76 billion for the quarter, compared to analyst estimates of $6.62 billion. Danaher had a net margin of 18.05% and a trailing twelve-month return on equity of 12.94%. The company's quarterly revenue was up 38.9% on a year-over-year basis. During the same period last year, the business earned $1.28 EPS.
View Danaher's earnings history
.

How has Danaher's stock price been impacted by COVID-19 (Coronavirus)?

Danaher's stock was trading at $139.37 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, DHR shares have increased by 56.7% and is now trading at $218.35.
View which stocks have been most impacted by COVID-19
.

How often does Danaher pay dividends? What is the dividend yield for Danaher?

Danaher declared a quarterly dividend on Tuesday, February 23rd. Shareholders of record on Friday, March 26th will be given a dividend of $0.21 per share on Friday, April 30th. This represents a $0.84 dividend on an annualized basis and a yield of 0.38%. The ex-dividend date of this dividend is Thursday, March 25th. This is a boost from Danaher's previous quarterly dividend of $0.18.
View Danaher's dividend history
.

Is Danaher a good dividend stock?

Danaher pays an annual dividend of $0.72 per share and currently has a dividend yield of 0.33%. Danaher has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strock track record of dividend growth. The dividend payout ratio of Danaher is 16.29%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Danaher will have a dividend payout ratio of 9.97% next year. This indicates that Danaher will be able to sustain or increase its dividend.
View Danaher's dividend history.

What guidance has Danaher issued on next quarter's earnings?

Danaher updated its fourth quarter 2020 Pre-Market earnings guidance on Wednesday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $6.743-6.743 billion, compared to the consensus revenue estimate of $6.44 billion.

What price target have analysts set for DHR?

14 equities research analysts have issued 12 month target prices for Danaher's stock. Their forecasts range from $190.00 to $280.00. On average, they expect Danaher's stock price to reach $237.07 in the next twelve months. This suggests a possible upside of 8.6% from the stock's current price.
View analysts' price targets for Danaher
or view top-rated stocks among Wall Street analysts.

Who are Danaher's key executives?

Danaher's management team includes the following people:
  • Mr. Steven M. Rales, Co-Founder & Chairman (Age 70)
  • Mr. Rainer M. Blair, Pres, CEO & Director (Age 57, Pay $2.56M) (LinkedIn Profile)
  • Mr. Mitchell P. Rales, Co-Founder & Director (Age 64)
  • Mr. Matthew R. McGrew, CFO & Exec. VP (Age 49, Pay $1.92M) (LinkedIn Profile)
  • Mr. Thomas P. Joyce Jr., Sr. Advisor (Age 60, Pay $5.87M)
  • Mr. Joakim Weidemanis, Exec. VP (Age 52, Pay $2.26M) (LinkedIn Profile)
  • Mr. Robert S. Lutz, Chief Accounting Officer & Sr. VP (Age 63)
  • Dr. Jose-Carlos Gutierrez-Ramos, Chief Scientific Officer & Sr. VP
  • Mr. Matthew E. Gugino C.F.A., CPA, CFA, CPA, VP of Investor Relations
  • Mr. Brian W. Ellis, Sr. VP, Gen. Counsel & Chief Compliance Officer (Age 54) (LinkedIn Profile)

What is Rainer M. Blair's approval rating as Danaher's CEO?

27 employees have rated Danaher CEO Rainer M. Blair on Glassdoor.com. Rainer M. Blair has an approval rating of 98% among Danaher's employees. This puts Rainer M. Blair in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Danaher's key competitors?

What other stocks do shareholders of Danaher own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Danaher investors own include NVIDIA (NVDA), The Home Depot (HD), The Walt Disney (DIS), Johnson & Johnson (JNJ), Adobe (ADBE), Intel (INTC), Alibaba Group (BABA), Mastercard (MA), PayPal (PYPL) and AbbVie (ABBV).

What is Danaher's stock symbol?

Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."

Who are Danaher's major shareholders?

Danaher's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.43%), Price T Rowe Associates Inc. MD (4.41%), FMR LLC (4.38%), Edgewood Management LLC (1.18%), Northern Trust Corp (1.18%) and Norges Bank (1.04%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King.
View institutional ownership trends for Danaher
.

Which institutional investors are selling Danaher stock?

DHR stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, UBS Asset Management Americas Inc., Findlay Park Partners LLP, Bessemer Group Inc., Jennison Associates LLC, Schroder Investment Management Group, Schroder Investment Management Group, and Aristotle Capital Management LLC. Company insiders that have sold Danaher company stock in the last year include Angela S Lalor, Daniel L Comas, Daniel Raskas, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, and William King.
View insider buying and selling activity for Danaher
or view top insider-selling stocks.

Which institutional investors are buying Danaher stock?

DHR stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Edgewood Management LLC, BlackRock Inc., D1 Capital Partners L.P., FMR LLC, Renaissance Technologies LLC, Healthcare of Ontario Pension Plan Trust Fund, and Healthcare of Ontario Pension Plan Trust Fund.
View insider buying and selling activity for Danaher
or or view top insider-buying stocks.

How do I buy shares of Danaher?

Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Danaher's stock price today?

One share of DHR stock can currently be purchased for approximately $218.35.

How much money does Danaher make?

Danaher has a market capitalization of $155.51 billion and generates $17.91 billion in revenue each year. The conglomerate earns $3.01 billion in net income (profit) each year or $4.42 on an earnings per share basis.

How many employees does Danaher have?

Danaher employs 60,000 workers across the globe.

Does Danaher have any subsidiaries?

The following companies are subsidiares of Danaher: AB SCIEX, AB Sciex Germany GmbH, AB Sciex KK, AB Sciex LLC, AB Sciex LP, AB Sciex Pte Ltd., AB Sciex Switzerland GmbH, AB Sciex UK Ltd., Accu-Sort Systems, Acme Cleveland Corporation, Advanced Vision Technology, Aguasin SpA, Alltec Angewandte Laserlicht Technologie GmbH, Alpha Biotec Ltd., American Precision Industries, Applied Biosystems, Aquafine Corporation, Aquafine GmbH, Aquatic Informatics, Armstrong Tools, BCK Holdings S.à.r.l., Beckman Australia ApS, Beckman Coulter, Beckman Coulter Australia Pty Ltd, Beckman Coulter Biomedical GmbH, Beckman Coulter Biotechnology (Suzhou) Co. Ltd., Beckman Coulter Biyomedikal Urunler Sanayi ve Ticaret Limited [irketi], Beckman Coulter Canada LP, Beckman Coulter Ceska republika s.r.o., Beckman Coulter Commercial Enterprise (China) Co. Ltd., Beckman Coulter España S.A., Beckman Coulter France S.A.S., Beckman Coulter G.m.b.H., Beckman Coulter Genomics Inc., Beckman Coulter Hong Kong Limited, Beckman Coulter Inc., Beckman Coulter India Private Limited, Beckman Coulter International SA, Beckman Coulter International Shanghai Trading Co., Beckman Coulter Ireland Inc., Beckman Coulter K.K., Beckman Coulter Korea Ltd., Beckman Coulter Laboratory Systems (Suzhou) Co. Ltd., Beckman Coulter Limited Liability Company, Beckman Coulter Mishima K.K., Beckman Coulter Nederland B.V., Beckman Coulter S.L., Beckman Coulter South Africa (Proprietary) Limited, Beckman Coulter Srl, Beckman Coulter Taiwan Inc., Beckman Coulter United Kingdom Limited, Beckman Coulter de Mexico S.A. de C.V., Beckman Coulter do Brasil Ltda., Beckman Countler Nippon GK, BioTector Analytical Systems Ltd, Carnassial Corporation, Cepheid, ChemTreat, ChemTreat Inc., Coulter Electronics Pty. Limited, Cytiva, DANRAD ApS, DANRAD Holding ApS, DH Acquisition Holding GmbH, DH Alpha Limited, DH Business Services LLC, DH Canada Holding ULC, DH Europe Finance SA, DH Holding Italia SRL, DH Holdings Corp., DH Operations BV, DH Switzerland Finance SA, DH Technologies Development Pte Ltd., DM HoldCo GmbH, DTIL Ireland Holdings Ltd., DUKI (2006) Finance Limited, Danaher (Shanghai) Management Co. Ltd., Danaher Evolution GmbH, Danaher Medical ApS, Delta Consolidated Industries, Dental Imaging Technologies Corporation, Devicore Medical Products Inc., Easco Hand Tools, Esko, Esko BVBA, Esko Brno S.r.o, Esko-Graphics BVBA, Esko-Graphics Inc., FFCL Cayman Ltd., FJ 900 Inc., Fluke Corporation, GE Biopharma, Gelman Sciences Inc., Gendex, Genetix Group, Gilbarco Veeder Root, HIC Canada LP, Hach Company, Hach Lange GmbH, Hach Lange Sàrl, Hach Water Quality Analytical Instru. (Shanghai) Co. Ltd., HemoCue AB, Hybritech Incorporated, Hybritech International Incorporated, IDBS Group, IRIS International, Imaging Sciences International, Immunotech SAS, Immunotech Sro, Implant Direct Sybron Administration LLC, Implant Direct Sybron International LLC, Implant Direct Sybron Manufacturing LLC, Integrated DNA Technologies, Iris International Inc., Joslyn Holding Company LLC, KAVO Dental GmbH, KFL Finance Ltd., KaVo, KaVo Dental Holding GmbH, KaVo Kerr, KaVo do Brasil Indústria e Comércio Ltda., Kaltenbach & Voigt, Kaltenbach & Voigt GmbH, Kavo Dental Technologies LLC, Keithley Instruments, Kerr Corporation, KerrHawe SA, Kollmorgen, Laetus, Laetus GmbH, Leica Biosystems Melbourne Pty Ltd, Leica Biosystems Newcastle Limited, Leica Biosystems Nussloch GmbH, Leica Instruments (Singapore) Pte Limited, Leica Microsystems, Leica Microsystems (UK) Limited, Leica Microsystems CMS GmbH, Leica Microsystems IR GmbH, Leica Microsystems Inc., Leica Microsystems KK, Leica Microsystems Limited, Leica Microsystems Ltd. Shanghai, Leica Mikrosysteme (Austria) GmbH, Leica Mikrosysteme Vertrieb GmbH, Life Sciences Holdings France SAS, Lifschultz Industries, Linx Printing Technologies, Linx Printing Technologies Limited, Lipesa Colombia SA, Lumigen Inc., MDS Analytical Technologies, Marconi Data Systems, McCrometer Inc., Metrex Research LLC, Microtest, Molecular Devices, Molecular Devices LLC, Navman Wireless, Navman Wireless OEM Solutions, Nihon Pall Manufacturing Limited, Nobel Biocare, Nobel Biocare AB, Nobel Biocare Canada Inc., Nobel Biocare Deutschland GmbH, Nobel Biocare India Pvt.Ltd., Nobel Biocare Japan KK, Nobel Biocare Procera KK, Nobel Biocare Services AG, Nobel Biocare USA LLC, Ormco BV, Ormco Corporation, Pall, Pall (Canada) Limited, Pall (Schweiz) AG, Pall Acquisition LLC, Pall Aeropower Corporation, Pall Asia Holdings Inc., Pall Australia Pty. Ltd., Pall Austria Filter Ges.m.b.h, Pall Biomedical Inc., Pall Deutschland Holding GmbH & Co., Pall Europe Limited, Pall Filter (Beijing) Co. Ltd., Pall Filtersystems GmbH, Pall Filtration Pte. Ltd., Pall Filtration and Separations Group, Pall ForteBio LLC, Pall France SAS, Pall GmbH, Pall International Sarl, Pall Italia Srl, Pall Korea Ltd., Pall Life Sciences Belgium BVBA, Pall Life Sciences Puerto Rico LLC, Pall Manufacturing UK Limited, Pall Medistad BV, Pall Netherlands BV, Pall Puerto Rico Inc., PaloDEX, PaloDEx Group OY, Pantone LLC, Pelton & Crane, Phenomenex, Phenomenex Inc., QH HoldCo GmbH, Radiometer, Radiometer, Radiometer America Inc., Radiometer GmbH, Radiometer K.K., Radiometer Medical Equipment (Shanghai) Co. Ltd., Radiometer Turku Oy, Raytek, Reytek Corporation, Sea-Bird Electronics Inc., Shanghai AB Sciex Analytical Instrument Trading Co. Ltd., SpofaDental a.s., Sutron, Sybron Canada LP, Sybron Canada Limited Partner Company, Sybron Dental Specialties, Sybron Dental Specialties Inc., TH Finance Limited, Tektronix, Thomson Industries, Trojan Technologies, U.S. Peroxide LLC, VR Finance Company, VSS Monitoring, Videojet Argentina S.R.L., Videojet China Trading, Videojet Do Brasil Comércio de Equipamentos Para Codificação Industrial Ltda., Videojet Technologies (I) Pvt. Ltd, Videojet Technologies Europe B.V., Videojet Technologies Inc., Viqua, Viridor Waste Management Limited, Vision Systems Limited, Willett International, X-Rite, X-Rite Asia Pacific Limited, X-Rite Europe GmbH, X-Rite Incorporated, XOS, and Zhuhai S.E.Z. Videojet Electronics Ltd..

When was Danaher founded?

Danaher was founded in 1984.

What is Danaher's official website?

The official website for Danaher is www.danaher.com.

Where are Danaher's headquarters?

Danaher is headquartered at 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037.

How can I contact Danaher?

Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]


This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.